Please provide your email address to receive an email when new articles are posted on . “Considered as a whole, the evidence would seem to suggest that repeat DKA embodies a ‘perfect storm’ of ...

While rare, diabetic ketoacidosis occurs overwhelmingly in patients taking SGLT2 inhibitors with type 2 diabetes, according to the analysis from 3 North Carolina medical schools. A data analysis in ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from ...

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are two serious complications of diabetes that are potentially life threatening. Both involve a dangerous rise in sugar levels, ...

Please provide your email address to receive an email when new articles are posted on . “Any barriers that delay the acute presentation to the health system, be it at a doctor's office or clinic, must ...

DKA is a complication of diabetes that can cause many symptoms. Various lab tests can confirm a diagnosis of DKA. These include ABG tests, which measure different components of the blood. In this ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can’t produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids ...

Patients with SGLT2 inhibitor-associated diabetic ketoacidosis (DKA) received significantly lower doses of insulin in the first 24 hours of treatment compared with patients with type 1 diabetes DKA, ...

Hyperglycemic hyperosmolar nonketotic syndrome (HHNS) is also known as hyperglycemic hyperosmolar syndrome (HHS). It involves very high blood sugar levels and can be life threatening. HHNS can happen ...

Levels of kidney function alone had no apparent impact on the risk for diabetic ketoacidosis (DKA) among adults with type 1 diabetes (T1D), regardless of the use of kidney protective medication, ...